Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
株式のランク #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
株価
$0.0202
最終同期: 2024-11-19
時価総額
$44.67K
変化(1日)
-0.49%
変化(1年)
0.00%
IL
取引 Notable Labs, Ltd. (NTBL)

カテゴリー

Notable Labs, Ltd.(NTBL)の配当利回りの履歴
Notable Labs, Ltd.(銘柄コード: NTBL)の配当利回り(TTM)は2022-12-31時点で0.00%です。
過去5年間の平均配当利回り: 0.00%
Notable Labs, Ltd.(NTBL)の2015から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
類似企業または競合他社の配当利回り(TTM)